InflaRx NV (IFRX)
1.38
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
1.36
-0.02
(-1.45%)
After-Hours: 20:00
InflaRx Cash and Short Term Investments (Quarterly): 99.79M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 99.79M |
| September 30, 2023 | 121.43M |
| June 30, 2023 | 111.18M |
| March 31, 2023 | 74.49M |
| December 31, 2022 | 87.73M |
| September 30, 2022 | 97.87M |
| June 30, 2022 | 104.96M |
| March 31, 2022 | 100.47M |
| December 31, 2021 | 94.44M |
| September 30, 2021 | 108.94M |
| June 30, 2021 | 151.37M |
| March 31, 2021 | 161.27M |
| December 31, 2020 | 99.79M |
| September 30, 2020 | 112.00M |
| Date | Value |
|---|---|
| June 30, 2020 | 110.88M |
| March 31, 2020 | 118.86M |
| December 31, 2019 | 129.36M |
| September 30, 2019 | 149.21M |
| June 30, 2019 | 157.91M |
| March 31, 2019 | 169.40M |
| December 31, 2018 | 179.10M |
| September 30, 2018 | 129.32M |
| June 30, 2018 | 189.72M |
| March 31, 2018 | 142.08M |
| December 31, 2017 | 147.90M |
| September 30, 2017 | 26.02M |
| June 30, 2017 | 28.98M |
| December 31, 2016 | 30.78M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
74.49M
Minimum
Mar 2023
161.27M
Maximum
Mar 2021
115.37M
Average
110.88M
Median
Jun 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Affimed NV | 80.58M |
| MorphoSys AG | 754.72M |
| BioNTech SE | 18.29B |
| Immatics NV | 470.78M |
| CureVac NV | 447.81M |